TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
As many as 30% of depressed patients fail to respond to treatment with an antidepressant and at least 60% to 75% may fail to achieve complete remission. 57 In its broadest form, treatment-resistant depression may characterize the majority of depressed patients in therapy and may contribute to the overwhelming morbidity and mortality rates associated with affective illness, 36 , 38 and may account for a disproportionate amount of physician treatment time. The paucity of attention given to treatment-resistant depression has led to inconsistent and confusing treatment approaches that all too often have resulted in a sense of “therapeutic nihilism” among clinicians and patients alike. Moreover, recent data have suggested the possibility that repeated drug trials per se may contribute to treatment-resistant depression. Thus, we recently found that the number of prior drug treatments negatively influenced the response to each succeeding antidepressant treatment in patients with treatment-resistant depression (odds ratio = 0.80). This indicates that the odds of responding to the next antidepressant treatment declines by a factor of approximately 15% to 20% for each prior failed drug treatment. 4 Although many patients with treatment-resistant depression do respond eventually to some drug combination or less conventional drug augmentation strategy, many of these therapies may be associated with an increased risk of drug-drug interactions and certainly require an extended time frame to accommodate a “trial and error” approach. To optimize treatment and to choose more rationally among the vast array of drug combinations and augmentation strategies for treatment-resistant depression, a series of empirically derived treatment algorithms have begun to emerge that may represent a more systematic and less haphazard treatment approach. In a systematic approach, a particular treatment strategy should be (1) shown to be either superior to a comparative treatment in controlled drug trials or superior to other treatments in a series of uncontrolled case reports and (2) based on sound psychopharmacologic theory. In every instance, the risk-to-benefit ratio must be assessed and found to be in the patient's best interest. This article lays a groundwork for efficiently diagnosing and treating the patient with treatment-resistant depression by applying empirically based, systematic treatment algorithms. In this fashion, a safe and aggressive approach can be undertaken in the treatment of treatment-resistant depression in order to reduce the substantial illness-related morbidity and mortality rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tranylcypromine versus imipramine in anergic bipolar depression
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.910 · Cited by 360
Cited by
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“…treatment approaches (algorithms) is that decreasing the variance and increasing the appropriateness of treatment strategies results in enhanced patient outcomes and avoidance of development of refractoriness (Amsterdam and Hornig-Rohan 1996; Gilbert et al. 1998; Rush et al. 1998; Rush 1999).”
BackgroundA Novel Augmentation Strategy for Treating Resistant Major Depression
Shelton, R. C., Tollefson, G. D., Tohen, M., Stahl, S., Gannon, K. S., Jacobs, T. G., Buras, W. R., Bymaster, F. P., Zhang, W., Spencer, K. A., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.131 · Cited by 504
Treatment resistant depression: methodological overview and operational criteria
Souery, D., Amsterdam, J., de Montigny, C., Lecrubier, Y., Montgomery, S., Lipp, O., Racagni, G., Zohar, J., & Mendlewicz, J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00004-2 · Cited by 444
Self-citationBauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Trivedi, M. H., Rush, A. J., Crismon, M. L., Kashner, T. M., Toprac, M. G., Carmody, T. J., Key, T., Biggs, M. M., Shores-Wilson, K., Witte, B., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.669 · Cited by 316
Metadata
- Authors
- Amsterdam, J. D., & Hornig-Rohan, M.
- Venue
- Psychiatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 1996-06
- Volume
- 19
- Issue
- 2
- Pages
- 371-386
- ISSN
- 0193-953X (ISSN-L)
- OpenAlex
- W2078374346
- Cited by
- 97
- References
- 1
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION. https://app.cochat.ai/papers/10.1016/s0193-953x(05)70293-8
- The paper
- Amsterdam, J. D., & Hornig-Rohan, M. (1996). TREATMENT ALGORITHMS IN TREATMENT-RESISTANT DEPRESSION. Psychiatric Clinics of North America. https://doi.org/10.1016/s0193-953x(05)70293-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.